Leerink Partners Raises Price Target on Universal Health (UHS) Following 2Q EPS Beat

Go back to Leerink Partners Raises Price Target on Universal Health (UHS) Following 2Q EPS Beat

Universal Health (UHS) Tops Q2 EPS by 22c

July 30, 2015 5:01 PM EDT

Universal Health (NYSE: UHS) reported Q2 EPS of $1.85, $0.22 better than the analyst estimate of $1.63. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.19 billion.

For earnings history and earnings-related data on Universal Health (UHS) click here.

... More